NGS Chromosome Analysis: Next-Generation Genetic Screening for IVF

What Is NGS Chromosome Analysis in IVF?

Next-Generation Sequencing (NGS) is a major advance in genetic screening technology that has changed the field of in vitro fertilization. At GynoLife IVF Center in North Cyprus, NGS chromosome analysis is used to evaluate embryos at the genetic level before transfer, identifying chromosomal abnormalities that could lead to implantation failure, miscarriage, or genetic disorders in offspring.

Unlike older genetic screening methods, NGS analyzes all 23 pairs of chromosomes with high precision and reliability. This technology reads the complete genetic makeup of embryonic cells, detecting even subtle chromosomal imbalances that earlier techniques might miss. The result is a better-informed embryo selection process that significantly improves IVF outcomes.

NGS has become the gold standard for preimplantation genetic testing (PGT) worldwide, replacing older technologies such as array comparative genomic hybridization (aCGH) and fluorescence in situ hybridization (FISH). Its higher resolution, greater throughput, and cost-effectiveness make it the preferred choice for modern fertility clinics that aim to deliver the best possible results.

How NGS Technology Works

Understanding the science behind NGS helps patients appreciate the strength and precision of this genetic screening tool.

The Biopsy Process

NGS analysis begins with a small biopsy of the embryo, usually carried out at the blastocyst stage on day five or six of development. An experienced embryologist carefully removes three to five cells from the trophectoderm, the outer cell layer that will go on to form the placenta. This procedure does not harm the inner cell mass, which develops into the baby, and decades of research and clinical practice have shown it to be safe.

DNA Amplification and Sequencing

The biopsied cells contain only a tiny amount of DNA, so the first step is whole genome amplification (WGA), which makes millions of copies of the DNA to provide enough material for analysis. The amplified DNA is then broken into fragments, tagged with molecular barcodes, and run through the NGS sequencing platform.

The sequencer reads millions of short DNA fragments at the same time, mapping them back to the reference human genome. Advanced bioinformatics software analyzes the data to determine the copy number of each chromosome, identifying any gains (trisomies) or losses (monosomies) across all 23 chromosome pairs.

Results Interpretation

The analysis produces a detailed report for each embryo, classifying it as euploid (normal chromosome count), aneuploid (abnormal chromosome count), or mosaic (a mix of normal and abnormal cells). Our geneticists and fertility specialists review these results together to guide embryo selection decisions.

Benefits of NGS Screening for IVF Patients

NGS chromosome analysis offers many advantages that directly affect treatment success and the patient experience.

Higher Implantation Rates

By selecting only chromosomally normal embryos for transfer, NGS greatly increases the chance of successful implantation. Studies have shown that euploid embryo transfers reach implantation rates above 60 percent, compared with roughly 30-40 percent for unscreened embryos. This means fewer transfer attempts are needed to achieve pregnancy.

Reduced Miscarriage Risk

Chromosomal abnormalities are the leading cause of first-trimester miscarriage, accounting for roughly 50-70 percent of all pregnancy losses. NGS screening identifies aneuploid embryos before transfer, significantly lowering the risk of miscarriage and the emotional and physical toll it takes on patients.

Shorter Time to Pregnancy

By avoiding the transfer of chromosomally abnormal embryos that are unlikely to lead to a healthy pregnancy, NGS helps patients reach their goal sooner. This means fewer treatment cycles, less medication, lower costs, and less emotional stress over time.

Single Embryo Transfer Confidence

With NGS screening, clinicians can confidently recommend single embryo transfer (SET), knowing that the selected embryo has the best possible chance of success. This approach all but removes the risk of twin or triplet pregnancies, which carry significantly higher risks for both mother and babies.

Detection of Structural Abnormalities

Advanced NGS platforms can detect not only whole chromosome gains and losses but also segmental aneuploidies, where only part of a chromosome is duplicated or deleted. These structural abnormalities, which older screening methods might miss, can cause significant developmental problems.

Who Should Consider NGS Screening?

While any IVF patient can benefit from NGS chromosome analysis, it is especially recommended for certain groups:

• Women over 35: The risk of chromosomal abnormalities rises significantly with maternal age. NGS helps identify the best embryos from a group that may include a higher proportion of aneuploid embryos.
• Patients with recurrent miscarriage: If you have had two or more pregnancy losses, NGS can determine whether chromosomal factors are contributing to the problem.
• Couples with previous IVF failures: Repeated implantation failure may be caused by unknowingly transferring aneuploid embryos. NGS screening can break this cycle.
• Known chromosomal translocation carriers: Patients who carry balanced translocations produce a higher proportion of unbalanced embryos. NGS identifies which embryos are safe to transfer.
• Patients seeking gender selection: NGS can determine the sex of each embryo, allowing family balancing where legally permitted.
• Couples wanting to keep treatment cycles to a minimum: By giving each transfer the best chance of success, NGS reduces the total number of cycles needed.

NGS vs. Older Genetic Screening Methods

To appreciate the advantages of NGS, it helps to understand how it compares with earlier technologies.

NGS vs. FISH

Fluorescence in situ hybridization (FISH) was the first widely used PGT method, but it could only analyze a limited number of chromosomes, usually five to twelve. NGS screens all 23 pairs at once with higher accuracy, which has made FISH largely obsolete for routine PGT screening.

NGS vs. aCGH

Array comparative genomic hybridization (aCGH) was a major improvement over FISH because it analyzed all chromosomes. However, NGS offers several advantages over aCGH: higher resolution for detecting segmental abnormalities, better detection of mosaicism, the ability to process multiple samples at once, and lower per-sample costs.

NGS vs. qPCR

Quantitative polymerase chain reaction (qPCR) is another screening method that analyzes all chromosomes. It is effective, but NGS provides higher resolution and can detect a wider range of abnormalities, including low-level mosaicism and small segmental changes.

The NGS Screening Process at GynoLife IVF Center

At GynoLife, we have built NGS screening into our IVF protocols so that patients receive the most advanced care available.

Treatment Timeline

A typical IVF cycle with NGS screening usually follows these stages:

• Days 1-12: Ovarian stimulation with fertility medications to produce multiple eggs.
• Day 12-14: Egg retrieval procedure under light sedation.
• Day 0: Fertilization using ICSI (intracytoplasmic sperm injection) for optimal results.
• Days 1-5: Embryo culture in our advanced laboratory incubators.
• Day 5-6: Trophectoderm biopsy of blastocyst-stage embryos.
• Days 6-13: NGS analysis at the genetics laboratory (results are usually available within 7-10 days).
• Embryo vitrification: All biopsied embryos are vitrified (flash-frozen) while awaiting results.
• Frozen embryo transfer: Euploid embryos are transferred in a later cycle, once the endometrium has been prepared.

Our Laboratory Standards

GynoLife IVF Center holds its laboratory to high standards for NGS screening. Our embryology team has broad experience in blastocyst biopsy, and our genetics partners work with validated NGS platforms and strict quality control protocols. Every result is reviewed by experienced geneticists before it is shared with the clinical team.

Understanding Your NGS Results

When you receive your NGS results, each embryo will fall into one of the following categories:

Euploid (Normal)

These embryos have the correct number of chromosomes (46, or 23 pairs) and are suitable for transfer. Euploid embryos have the highest chance of successful implantation and a healthy pregnancy.

Aneuploid (Abnormal)

These embryos have one or more chromosome abnormalities, such as an extra chromosome (trisomy) or a missing chromosome (monosomy). Aneuploid embryos are generally not recommended for transfer, since they are unlikely to implant successfully and may lead to miscarriage.

Mosaic

Mosaic embryos contain a mix of normal and abnormal cells. The clinical significance of mosaicism is still being studied, but low-level mosaic embryos may be considered for transfer when no euploid embryos are available, after careful counseling about the possible risks and outcomes.

Combining NGS with Other Advanced Technologies

At GynoLife IVF Center, NGS screening can be combined with other advanced technologies to further improve outcomes:

• EmbryoScope time-lapse monitoring: Continuous monitoring of embryo development adds morphological data that complements the genetic information.
• ERA (Endometrial Receptivity Analysis): Identifying the optimal window of implantation helps ensure that genetically normal embryos are transferred at the best possible time.
• PGT-M for monogenic disorders: Besides chromosome screening, NGS can be set up to test for specific single-gene disorders such as cystic fibrosis, sickle cell disease, or thalassemia.

Frequently Asked Questions About NGS Screening

Is the embryo biopsy safe?

Yes. Trophectoderm biopsy has been performed for over two decades, supported by a large body of safety data. Studies consistently show that biopsied embryos develop normally and that children born after PGT have the same health outcomes as those conceived without biopsy.

Does NGS guarantee a healthy baby?

NGS screens for abnormalities in chromosome number and large structural changes, but it does not test for every possible genetic condition. It significantly lowers the risk of chromosomal disorders and miscarriage, but it cannot guarantee a fully healthy outcome, just as no prenatal test can.

What if all my embryos are abnormal?

This outcome, though disappointing, gives valuable information. It may explain previous IVF failures and helps your medical team adjust the treatment plan. Options may include additional IVF cycles, changes to the stimulation protocol, or considering donor gametes.

How much does NGS screening add to the cost of IVF?

At GynoLife IVF Center, we offer NGS screening at competitive prices that are good value given the marked improvement in success rates. The cost is a fraction of what patients would pay at clinics in Western Europe or the United States.

Start Your Journey with Confidence

NGS chromosome analysis is one of the most advanced genetic screening tools in reproductive medicine. By including it in your IVF treatment at GynoLife IVF Center, you can move through your fertility treatment with more confidence, knowing that every possible step has been taken to give you the best chance of a healthy pregnancy.

Our team of fertility specialists, embryologists, and genetic counselors is ready to walk you through every aspect of NGS screening and help you make informed decisions about your treatment.

Want to learn more about how NGS can improve your chances of IVF success? Schedule your free consultation with GynoLife IVF Center today.